GB9209513D0 - Use of mmp inhibitors in tumour regression - Google Patents

Use of mmp inhibitors in tumour regression

Info

Publication number
GB9209513D0
GB9209513D0 GB929209513A GB9209513A GB9209513D0 GB 9209513 D0 GB9209513 D0 GB 9209513D0 GB 929209513 A GB929209513 A GB 929209513A GB 9209513 A GB9209513 A GB 9209513A GB 9209513 D0 GB9209513 D0 GB 9209513D0
Authority
GB
United Kingdom
Prior art keywords
mmp inhibitors
tumour regression
tumour
regression
mmp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB929209513A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vernalis R&D Ltd
Original Assignee
British Bio Technology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Bio Technology Ltd filed Critical British Bio Technology Ltd
Priority to GB929209513A priority Critical patent/GB9209513D0/en
Publication of GB9209513D0 publication Critical patent/GB9209513D0/en
Priority to EP93911883A priority patent/EP0639982A1/en
Priority to AU42672/93A priority patent/AU4267293A/en
Priority to PCT/GB1993/000888 priority patent/WO1993021942A2/en
Priority to EP99114903A priority patent/EP1002556A3/en
Priority to ZA933089A priority patent/ZA933089B/en
Priority to US08/686,485 priority patent/US5872152A/en
Pending legal-status Critical Current

Links

GB929209513A 1992-05-01 1992-05-01 Use of mmp inhibitors in tumour regression Pending GB9209513D0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
GB929209513A GB9209513D0 (en) 1992-05-01 1992-05-01 Use of mmp inhibitors in tumour regression
EP93911883A EP0639982A1 (en) 1992-05-01 1993-04-29 Use of mmp inhibitors
AU42672/93A AU4267293A (en) 1992-05-01 1993-04-29 Use of MMP inhibitors
PCT/GB1993/000888 WO1993021942A2 (en) 1992-05-01 1993-04-29 Use of mmp inhibitors
EP99114903A EP1002556A3 (en) 1992-05-01 1993-04-29 Use of MMP inhibitors
ZA933089A ZA933089B (en) 1992-05-01 1993-04-30 Use of MMP inhibitors in tumour regression
US08/686,485 US5872152A (en) 1992-05-01 1996-07-26 Use of MMP inhibitors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929209513A GB9209513D0 (en) 1992-05-01 1992-05-01 Use of mmp inhibitors in tumour regression

Publications (1)

Publication Number Publication Date
GB9209513D0 true GB9209513D0 (en) 1992-06-17

Family

ID=10714905

Family Applications (1)

Application Number Title Priority Date Filing Date
GB929209513A Pending GB9209513D0 (en) 1992-05-01 1992-05-01 Use of mmp inhibitors in tumour regression

Country Status (2)

Country Link
GB (1) GB9209513D0 (en)
ZA (1) ZA933089B (en)

Also Published As

Publication number Publication date
ZA933089B (en) 1993-11-23

Similar Documents

Publication Publication Date Title
EP0764030A4 (en) Use of autoantibodies for tumor therapy and prophylaxis
HU9303218D0 (en) Application of atp-depended protease and its inhibitor for treatment of cachexy and amyotrophia
HU9202842D0 (en) Climotripsine-type proteases and inhibitors
WO1993021942A3 (en) Use of mmp inhibitors
DE3573429D1 (en) 17 beta-substituted-4-aza-5-alpha-androstenones and their use as 5-alpha-reductase inhibitors
IL108075A0 (en) Enzyme inhibitors
HU9802464D0 (en) Use of mmp-13 selective inhibitors for treating osteoarthritis and other mmp induced diseases
ZA939032B (en) Tampon applicator
HK1023561A1 (en) Sulfonamide inhibitors of hiv-aspartyl protease
PL314838A1 (en) Inhibitors of bp-iv-serine protease
GB9227026D0 (en) Dual inhibitors of no synthase and cycloosygenase
IL105521A0 (en) The use of inhibitors of plasminogen activators for the treatment of inflammations and wounds
EP0390317A3 (en) Corrosion inhibitor and its use
AU5730286A (en) Treatment of factor viii inhibitors
GB9208921D0 (en) Electrochemical treatment of surfaces
HU893412D0 (en) Inhibitors of interleucin-1
EP0450598A3 (en) Inhibitors of the advanced glycosylation of proteins and methods of use therefor
AP9300555A0 (en) Therapeutic agent and its use
HK1010672A1 (en) Tampon applicator
DE3666826D1 (en) Human natural inhibitor of collagenases
ZA934970B (en) Enzyme inhibitors
EP0713496A4 (en) Fibrin-targeted inhibitors of thrombin
GB9209513D0 (en) Use of mmp inhibitors in tumour regression
GB9219776D0 (en) New compounds for use in the treatment of cancer
GB9305467D0 (en) Substituted cephalosporin sulfones useful in the treatment of cancer